SELLAS Life Sciences Group, Inc.SLSNASDAQ
Loading
SG&A Expenses Over TimeStable
Percentile Rank50
3Y CAGR-0.9%
5Y CAGR+5.0%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
-0.9%/yr
vs -0.4%/yr prior
5Y CAGR
+5.0%/yr
Recent deceleration
Acceleration
-0.5pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive declineStable
PeriodValueYoY Change
TTM$12.25M-1.3%
2024$12.42M-10.4%
2023$13.86M+10.2%
2022$12.58M+11.1%
2021$11.32M+17.9%
2020$9.60M-3.3%
2019$9.92M-22.3%
2018$12.77M-15.4%
2017$15.09M+25.7%
2016$12.01M-